EMA’s July 23, 2025 effective date for ICH E6(R3) is no longer a distant milestone for European portfolios it is an active operational deadline. For Regulatory, Clinical Operations, and Quality heads at biotech sponsors and mid-size CROs, this shift lands in an environment where capital constraints make reactive Trial Master File (TMF) remediation an expensive operational drag that companies can no longer afford.
The historical approach of running manual document cleanups before clinical milestones or inspections is structurally broken under modern frameworks:
Cloudbyz addresses this regulatory gap through a 100% Salesforce-native unified infrastructure that natively bridges Clinical Trial Management Systems (CTMS) and eTMF workflows. By connecting operational activities directly to compliance documentation, the platform ensures that system milestones automatically trigger and reconcile against document requirements in real time.
Operating inside this integrated ecosystem, the Cloudbyz eTMF AI Agent acts as an intelligent first layer of defense at the source of document ingestion, executing critical tasks the moment a file is uploaded:
Maintaining a defensible data integrity posture requires compliance with frameworks like the EMA’s notice on computerised system validation. On a native Cloudbyz spine, every automated action, classification shift, and metadata adjustment completed by the AI Agent is fully attributable, time-stamped, and recorded within an unalterable audit trail. This gives clinical operations and QA leaders an audit-ready platform that aligns with ALCOA+ principles and 21 CFR Part 11 requirements.
Ultimately, unifying your CTMS operations with an intelligent eTMF AI Agent ensures that essential-record gaps are visible alongside site progress. Compliance stops being an exhausting, episodic event it simply becomes the natural byproduct of how you run your trial.
If your team is looking for a strategic way to reduce manual document intake friction, lower TMF remediation costs, and ensure continuous inspection readiness for your global portfolio, let's connect.